Preparation and physicochemical and preclinical evaluations of recrystallized celecoxib

PDA Journal of Pharmaceutical Science and Technology

Volumn 61, Issue 5, 2007, Pages 362-374

  Mutalik, S ^a,c   Usha, N ^a   Ranjith, A K ^a   Umesh, S ^b   Musmade, P ^a   Anup, N ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b Torrent Pharmaceutical   (India)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Analgesic; Celecoxib; Pharmacokinetics; Polyethylene glycol; Recrystallization; Solvent change method; Tween 80

Indexed keywords

CELECOXIB; DRUG CARRIER; MACROGOL 400; POLYSORBATE 80;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DETERMINATION; DRUG MECHANISM; DRUG SOLUBILITY; IN VIVO STUDY; INFRARED RADIATION; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ACETIC ACID; ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; HEAT; MICE; MICROSCOPY, ELECTRON, SCANNING; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYSORBATES; PYRAZOLES; SOLUBILITY; SOLVENTS; SPECTROPHOTOMETRY, INFRARED; SULFONAMIDES;

EID: 37349038520     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Connor, E. P. Physicians' Desk Reference, 57th ed.; Medical Economics Company Inc.: Montvale, NJ, 2003.
2. Davies, N. M.; Mclachlan, A. J.; Day, R. O.; Williams, K. M. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin. Pharmacokinet. 2002, 38 (3), 225-242.
3. Jackson, L. M.; Hawkey, C. J. COX-2 selective nonsteroidal anti-inflammatory drugs: do they really offer any advantages? Drugs 2000, 59 (6), 1207-1216.
4. Nagarsenker, M. S.; Joshi, M. S. Celecoxib-cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage. Drug Dev. Ind. Pharm. 2005, 31 (2), 169-178.
5. Seedhar, N.; Bhatia, S. Solubility enhancement of Cox-2 inhibitors using various solvent systems. AAPS PharmSciTech 2003, 4 (3), E33.
6. Devi, V. K.; Vijayalakshmi, P.; Avinash, M. Pre-formulation studies on celecoxib with a view to improve bioavailability. Indian J. Pharm. Sci. 2003, 65 (5), 542-545.
7. Gupta, P.; Kakumanu, V. K.; Bansal, A. K. Stability and solubility of celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 2004, 21 (10), 1762-1769.
8. Gupta, P.; Bansal, A. K. Molecular interactions in celecoxib-PVP- meglumine amorphous system. J. Pharm. Pharmacol. 2005, 57 (3), 303.
9. Gupta, P.; Bansal, A. K. Spray drying for generation of a ternary amorphous system of celecoxib, PVP and meglumine. Pharm. Dev. Technol. 2005, 10 (2), 273-281.
10. Rawat, S.; Jain, S. K. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes. Eur. J. Pharm. Biopharm. 2004, 57 (2), 263-267.
11. Chandra Sekhara Rao, G.; Satish Kumar, M.; Mathivanan, N.; Bhanoji Rao, M. E. Improvement of physical stability and dissolution rate of celecoxib suspensions by complexation with beta-cyclodextrins. Pharmazie 2004, 59, 627.
12. Reddy, M. N.; Rehana, T.; Ramakrishna, S.; Chowdhary, K. P.; Diwan, P. V. Beta cyclodextrin complexes of celecoxib: molecular modeling, characterization and dissolution studies. AAPS PharmSciTech 2004, 6 (1), E7.
13. Ventura, C. A.; Giannone, I.; Paolino, D.; Pistara, V.; Corsaro, A.; Puglisi, G. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study. Eur. J. Med. Chem. 2005, 40 (7), 624-631.
14. Sinha, V. R.; Anitha, R.; Ghosh, S.; Nanda, A.; Kumria, R. Complexation of celecoxib with β-cyclodextrin: characterization of the interaction in solution and solid state. J. Pharm. Sci. 2005, 94, 676-687.
15. Manzoori, J. L.; Abdolmohammad-Zadeh, H.; Amjadi, M. Study on the inclusion complex between beta-cyclodextrin and celecoxib by spectrofluorimetry and its analytical application. Farmaco. 2005, 60, 575.
16. Subramanian, N.; Ray, S.; Ghosal, S. K.; Bhadra, R.; Moulik, S. P. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull. 2004, 27, 1993-1999.
17. Lu, G. W.; Hawley, M.; Smith, M.; Geiger, B. M.; Pfund, W. Characterization of a novel polymorphic form of celecoxib. J. Pharm. Sci. 2006, 95, 305-317.
18. Paradkar, A.; Maheshwari, M.; Kambli, R.; Grimsey, I.; York, P. Design and evaluation of celecoxib porous particles using melt sonocrystallization. Pharm. Res. 2006, 23 (6), 1395-1400.
19. Mutalik, S.; Venkatesh, M.; Udupa, N. Fast analgesic activity from recrystallized nimesulide and its solid dispersion. Indian J. Physiol. Pharmacol. 2002, 46 (1), 115-118.
20. Kapoor, A.; Mujumdar, D. K.; Yadav, M. R. Crystal forms of nimesulide-a sulfonanilide (non-steroidal anti-inflammatory drug). Indian J. Chem., B 1998, 37 (6), 572-575.
21. Ghosh, M. N. Fundamentals of Experimental Pharmacology, 2nd ed.; Scientific Book Agency: Calcutta, India, 1984.
22. Hossinzadeh, H.; Ramezani, M.; Fadishei, M.; Mahmoudi, M. Antinociceptive, antiinflammatory and acute toxicity effects of zhumeria majdae extracts in mice and rats. Phytomedicine 2002, 9 (2), 135-141.
23. Kulkarni, S. K. Hand Book of Experimental Pharmacology, 3rd ed.; Vallabh Prakashan: New Delhi, India, 1999; p 23.
24. Reddy, M. N.; Sujatha, P.; Chauhan, A. S.; Ramakrishna, S.; Diwan, P. V. A simple and sensitive reverse-phase high performance liquid chromatographic method for the determination of celecolxib in rat plasma. Indian J. Pharm. Sci. 2003, 65, 260.
25. Betageri, G. V.; Makarla, K. R. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int. J. Pharm. 1995, 126 (1), 155-160.
26. Liu, C.; Liu, C.; Desai, K. G. H. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev. Ind. Pharm. 2005, 31 (1), 1-10.
27. Serajuddin, A. T. M.; Sheen, P. C.; Augustine, M. A. Improved dissolution of a poorly water-soluble drug from solid dispersions in polyethylene glycol: Polysorbate 80 mixtures. J. Pharm. Sci. 1990, 79 (5), 463-464.
28. Babu, M. M. G. V.; Gouri Shankar, V.; Hima Sankar, K.; Sheshashayana, A.; Kishore Kumar, N.; Ramana Murthy, K. V. Development of dissolution medium for a poorly water soluble drug, celecoxib. Indian J. Pharm. Sci. 2002, 64 (6), 588-591.
29. Paradkar, A. R.; Pawar, A. P.; Chordiya, J. K.; Patil, V. B.; Ketkar, A. R. Spherical crystallization of celecoxib. Drug Dev. Ind. Pharm. 2002, 28 (10), 1213-1220.
30. Chiou, W. L.; Chen, S. J.; Athanikar, N. Enhancement of dissolution rates of poorly water-soluble drugs by crystallization in aqueous surfactant solutions. I: sulfathiazole, prednisone and chloramphenicol. J. Pharm. Sci. 1976, 65 (11), 1702-1704.